Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Neoplasms 5Pain 4Vomiting 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Nausea 3Colorectal Neoplasms 3Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Osteosarcoma 2Head and Neck Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Cancer Pain 2Anxiety Disorders 2Acupuncture 2Xerostomia 1Urinary Incontinence, Stress 1Urinary Incontinence 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Nausea and Vomiting 1

Interventions

Dexamethasone 5ramosetron 3Ondansetron 2Calcium Dobesilate 2Acupuncture Therapy 2phenazine 1esmolol 1Therapeutics 1Surveys and Questionnaires 1Sufentanil 1Promethazine 1Postoperative Care 1Olanzapine 1Gelatin 1Fentanyl 1Famotidine 1Electroacupuncture 1Electric Stimulation Therapy 1Electric Stimulation 1Diphenhydramine 1Dexmedetomidine 1Aprepitant 1Antiemetics 1Anesthesia, General 1Anesthesia 1Adrenergic beta-Antagonists 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Postoperative Nausea and Vomiting × Electroacupuncture × Clear all
NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Shanghai Chest Hospital

Phase NA Recruiting
204 enrolled

Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡